Rong Cheong Bio announced its 2024 “Enhancing the Effectiveness Review” Action Plan to enhance the company's core competitiveness, optimize team structure to promote commercialization, implement internationalization development strategy, strengthen investment project management to enhance technology innovation capacity, optimize financial management, improve operational efficiency, and improve corporate governance Improve the quality of information disclosure, strengthen investor communication, continue to improve investor feedback mechanisms, strengthen the constraints on shared interests of management and shareholders. The company will focus on operations, increase R&D investments, optimize marketing team structure, drive multi-center clinical trials and registration of drugs globally, and seek cooperation from multinational pharmaceutical companies. In addition, the Company will continue to pursue investment projects, including biopharmaceuticals, new anti-tumor antibody R...Show More

Rong Cheong Bio announced its 2024 “Enhancing the Effectiveness Review” Action Plan to enhance the company's core competitiveness, optimize team structure to promote commercialization, implement internationalization development strategy, strengthen investment project management to enhance technology innovation capacity, optimize financial management, improve operational efficiency, and improve corporate governance Improve the quality of information disclosure, strengthen investor communication, continue to improve investor feedback mechanisms, strengthen the constraints on shared interests of management and shareholders. The company will focus on operations, increase R&D investments, optimize marketing team structure, drive multi-center clinical trials and registration of drugs globally, and seek cooperation from multinational pharmaceutical companies. In addition, the Company will continue to pursue investment projects, including biopharmaceuticals, new anti-tumor antibody R&D projects, etc., to increase profitability. The company will also optimize financial management, improve profit quality and capital efficiency, and strengthen human resource management. RONG CHANG BIO WILL CONTINUE TO EVALUATE THE EXECUTION OF THE ACTION PLAN, FOCUS ON THE MAIN BUSINESS, PROMOTE THE STABLE AND HEALTHY DEVELOPMENT OF THE CAPITAL MARKET THROUGH GOOD OPERATIONAL MANAGEMENT, REGULATORY CORPORATE GOVERNANCE AND COMPREHENSIVE INVESTOR FEEDBACK.